263 related articles for article (PubMed ID: 12183689)
1. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
2. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
[TBL] [Abstract][Full Text] [Related]
3. VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent.
Jain J; Almquist SJ; Shlyakhter D; Harding MW
J Pharm Sci; 2001 May; 90(5):625-37. PubMed ID: 11288107
[TBL] [Abstract][Full Text] [Related]
4. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
6. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
7. Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Podar K; Le Gouill S; Shiraishi N; Yasui H; Roccaro AM; Tai YZ; Chauhan D; Fram R; Tamura K; Jain J; Anderson KC
Oncogene; 2005 Sep; 24(38):5888-96. PubMed ID: 15940263
[TBL] [Abstract][Full Text] [Related]
8. Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.
Nakanishi T; Morokata T; Kubo K; Umeno H; Eikyu Y; Kozuki Y; Seki N
Int Immunopharmacol; 2010 Jan; 10(1):91-7. PubMed ID: 19840872
[TBL] [Abstract][Full Text] [Related]
9. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
10. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
12. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
Dayton JS; Lindsten T; Thompson CB; Mitchell BS
J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
14. A novel series of non-nucleoside inhibitors of inosine 5'-monophosphate dehydrogenase with immunosuppressive activity.
Franklin TJ; Morris WP; Jacobs VN; Culbert EJ; Heys CA; Ward WH; Cook PN; Jung F; Plé P
Biochem Pharmacol; 1999 Sep; 58(5):867-76. PubMed ID: 10449198
[TBL] [Abstract][Full Text] [Related]
15. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).
Watterson SH; Chen P; Zhao Y; Gu HH; Dhar TG; Xiao Z; Ballentine SK; Shen Z; Fleener CA; Rouleau KA; Obermeier M; Yang Z; McIntyre KW; Shuster DJ; Witmer M; Dambach D; Chao S; Mathur A; Chen BC; Barrish JC; Robl JA; Townsend R; Iwanowicz EJ
J Med Chem; 2007 Jul; 50(15):3730-42. PubMed ID: 17585753
[TBL] [Abstract][Full Text] [Related]
16. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.
Yalowitz JA; Jayaram HN
Anticancer Res; 2000; 20(4):2329-38. PubMed ID: 10953293
[TBL] [Abstract][Full Text] [Related]
20. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.
Daxecker H; Raab M; Müller MM
Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
